Pain management of renal colic patients. Acute pain, not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group: In the first group, 30 mg of intravenous ketorolac will be administered within one minute and 5 mg of intravenous morphine (in a volume of 5 cc) will be prescribed
Sponsors
Zahedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 75 Years
Inclusion criteria
Inclusion criteria: Men or women will be 15 to 75 years old, who will be diagnosed with acute renal colic by radiography or ultrasound (based on the opinion of the emergency medicine doctor) They will get a score of 4 or higher on the visual analog scale (VAS). Hemodynamically stable (based on initial triage) Consent of patients or patients' companions to enter the study
Exclusion criteria
Exclusion criteria: Allergy to morphine, ketorolac or midazolam Renal dysfunction (according to GFR and BUN, Cr) Having one kidney or a history of kidney transplant Intravenous painkiller was consumed in 4 hours Paralytic ileus Heart failure due to chronic lung disease Convulsive disorders, acute respiratory failure Acute angle-closure glaucoma Severe low blood pressure or shock History of allergy to other NSAIDS Hemorrhagic disease Having coagulation disorders (or taking warfarin) Having vascular and cerebral lesions Having underlying diseases such as mental disorders, having fibromyalgia, cardiovascular disease, digestive diseases Drug addiction Pregnancy and breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Renal colic pain. Timepoint: At the beginning of the study and at 20, 40, 60 and 90 minutes after the intervention. Method of measurement: Visual analog scale.;Level of sedation. Timepoint: At the beginning of the study and at 20, 40, 60 and 90 minutes after the intervention. Method of measurement: Ramsay criterion.;Oxygen saturation percentage. Timepoint: At the beginning of the study and at 20, 40, 60 and 90 minutes after the intervention. Method of measurement: Pulse oximetry device.;Respiratory rate. Timepoint: At the beginning of the study and at 20, 40, 60 and 90 minutes after the intervention. Method of measurement: Counting by the nurse. | — |
Secondary
| Measure | Time frame |
|---|---|
| Headache. Timepoint: At 20, 40, 60 and 90 minutes after the intervention. Method of measurement: Having or not having a side effect after the intervention.;Hypotension or hypertension. Timepoint: At 20, 40, 60 and 90 minutes after the intervention. Method of measurement: Pressure gauge device.;Dizziness. Timepoint: At 20, 40, 60 and 90 minutes after the intervention. Method of measurement: Having or not having a side effect after the intervention.;Sleepiness. Timepoint: At 20, 40, 60 and 90 minutes after the intervention. Method of measurement: Having or not having a side effect after the intervention.;Decreased tendon reflex. Timepoint: At 20, 40, 60 and 90 minutes after the intervention. Method of measurement: Having or not having a side effect after the intervention.;Arrhythmia (tachycardia, bradycardia). Timepoint: At 20, 40, 60 and 90 minutes after the intervention. Method of measurement: Observation in monitoring.;Skin lesions. Timepoint: At 20, 40, 60 and 90 minutes after the intervention. Method of measurement: Observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Abdolrazaghnejad
Zahedan University of Medical Sciences
Outcome results
None listed